EUVIMEDEUVIMED entdecken
Crossref

α-Cyperone protects dopaminergic neurons and inhibits neuroinflammation in LPS-induced Parkinson’s disease rat model via activating Nrf2/HO-1 and suppressing NF-κB signaling pathway

Bingxu Huang, Guiqiu Hu, Xiaofeng Zong, Shuo Yang, Dewei He, Xiyu Gao, Dianfeng Liu

International Immunopharmacology · 2023

DOI: 10.1016/j.intimp.2023.109698 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2023. Verfasst von Bingxu Huang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Animals, College of Animal Science, Jilin University, Changchun, China. Hauptthemen laut MEDLINE: NF-kappa B, Parkinson Disease. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 71 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Our previous study showed that α-Cyperone inhibited the inflammatory response triggered by activated microglia and protected dopaminergic neuron in in vitro cell model of Parkinson's disease (PD). It is unclear the effect of α-Cyperone in animal models of PD. In this study, our results indicated that α-Cyperone ameliorated motor dysfunction, protected dopaminergic neurons, and inhibited the reduction of dopamine and its metabolites in lipopolysaccharide (LPS)-induced PD rat model. Moreover, α-Cyperone suppressed the activation of microglia and the expression of neuroinflammatory factor (TNF-α, IL-6, IL-1β, iNOS, COX-2 and ROS). Furthermore, the molecular mechanism research revealed that α-Cyperone inhibited neuroinflammation and oxidative stress to exert protective effect in microglia by activating Nrf2/HO-1 and suppressing NF-κB signaling pathway. Moreover, α-Cyperone upregulated the expression of antioxidant enzymes (GCLC, GCLM and NQO1) in microglia. In conclusion, our study demonstrates α-Cyperone alleviates dopaminergic neurodegeneration by inhibiting neuroinflammation and oxidative stress in LPS-induced PD rat model via activating Nrf2/HO-1 and suppressing NF-κB signaling pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-kappa BParkinson DiseaseRatsAnimalsLipopolysaccharidesDopaminergic NeuronsNF-E2-Related Factor 2Neuroinflammatory DiseasesAnti-Inflammatory AgentsSignal TransductionMicrogliaNaphthalenes

Stichwörter der Autor:innen

NeuroinflammationNrf2Oxidative stressParkinson's diseaseα-Cyperone

Substanzen

NF-kappa BLipopolysaccharidesNF-E2-Related Factor 2Anti-Inflammatory Agentsalpha-cyperoneNaphthalenes

Autor:innen und Institutionen

  • Department of Laboratory Animals, College of Animal Science, Jilin University, Changchun, China.
  • Department of Basic Veterinary Medicine, College of Veterinary Medicine, Jilin University, Changchun, China.
  • Department of Laboratory Animals, College of Animal Science, Jilin University, Changchun, China. Electronic address: ccldf@163.com.

Förderung

  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Huang, B., Hu, G., Zong, X., Yang, S., He, D., Gao, X., & Liu, D. (2023). α-Cyperone protects dopaminergic neurons and inhibits neuroinflammation in LPS-induced Parkinson’s disease rat model via activating Nrf2/HO-1 and suppressing NF-κB signaling pathway. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2023.109698

Vancouver

Huang B, Hu G, Zong X, Yang S, He D, Gao X, et al. α-Cyperone protects dopaminergic neurons and inhibits neuroinflammation in LPS-induced Parkinson’s disease rat model via activating Nrf2/HO-1 and suppressing NF-κB signaling pathway. International Immunopharmacology. 2023. doi:10.1016/j.intimp.2023.109698

BibTeX
@article{Huang2023,
  author = {Huang, Bingxu and Hu, Guiqiu and Zong, Xiaofeng and Yang, Shuo and He, Dewei and Gao, Xiyu and Liu, Dianfeng},
  title = {α-Cyperone protects dopaminergic neurons and inhibits neuroinflammation in LPS-induced Parkinson’s disease rat model via activating Nrf2/HO-1 and suppressing NF-κB signaling pathway},
  journal = {International Immunopharmacology},
  year = {2023},
  doi = {10.1016/j.intimp.2023.109698}
}
Kostenlos starten →